BMN 190
Biological
BioMarin Pharmaceutical Inc.
Total Payments
$218,035
Transactions
97
Doctors
66
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $218,035 | 97 | 66 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $161,822 | 8 | 74.2% |
| Education | $29,324 | 21 | 13.4% |
| Consulting Fee | $19,000 | 2 | 8.7% |
| Food and Beverage | $3,461 | 61 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 2 | 1.0% |
| Honoraria | $1,500 | 1 | 0.7% |
| Travel and Lodging | $677.54 | 2 | 0.3% |
Payments by Type
Research
$161,822
8 transactions
General
$56,213
89 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Pediatric Patients 18 Years of Age With CLN2 Disease | BioMarin Pharmaceutical Inc. | $75,314 | 0 |
| A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease | BioMarin Pharmaceutical Inc. | $51,650 | 0 |
| A Multicenter Multinational Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease | BioMarin Pharmaceutical Inc. | $24,183 | 1 |
| A Non-Interventional Observational Study of Pegvaliase-Naive Adults with Phenylketonuria PKU) Concept Elicitation and Cognitive Interviews | BioMarin Pharmaceutical Inc. | $10,675 | 0 |
Top Doctors Receiving Payments for BMN 190 — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatrics | Fort Worth, TX | $46.00 | 1 |
| , MD | Pediatrics | San Antonio, TX | $46.00 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | Jackson, MS | $46.00 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Birmingham, AL | $46.00 | 1 |
| , MD | Neurology | Hershey, PA | $46.00 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | Bentonville, AR | $46.00 | 1 |
| , DDS | Pediatric Dentistry | Riverview, MI | $46.00 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | New Orleans, LA | $46.00 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Baton Rouge, LA | $46.00 | 1 |
| , M.D | Pediatrics | Jackson, MS | $46.00 | 1 |
| Samiah Al-Zaidy | Neurology with Special Qualifications in Child Neurology | Columbus, OH | $46.00 | 1 |
| Louis Pena | General Practice | Lordsburg, NM | $45.50 | 1 |
| , M.D | Medical Biochemical Genetics | San Diego, CA | $45.50 | 1 |
| , MD | Pediatrics | Torrance, CA | $45.50 | 1 |
| , MD | Medical Genetics, Ph.D. Medical Genetics | Valhalla, NY | $45.50 | 1 |
| , M.D | Clinical Biochemical Genetics | Tacoma, WA | $17.88 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | San Bernardino, CA | $13.60 | 1 |
Ad
Manufacturing Companies
- BioMarin Pharmaceutical Inc. $218,035
Product Information
- Type Biological
- Total Payments $218,035
- Total Doctors 66
- Transactions 97
About BMN 190
BMN 190 is a biological associated with $218,035 in payments to 66 healthcare providers, recorded across 97 transactions in the CMS Open Payments database. The primary manufacturer is BioMarin Pharmaceutical Inc..
Payment data is available from 2017 to 2017. In 2017, $218,035 was paid across 97 transactions to 66 doctors.
The most common payment nature for BMN 190 is "Unspecified" ($161,822, 74.2% of total).
BMN 190 is associated with 4 research studies, including "A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Pediatric Patients 18 Years of Age With CLN2 Disease" ($75,314).